PD-animal models have indicated that repeated administration of NGF-dipeptide improved behavioral outcomes and exhibited neuroprotective effects against neuronal death caused by mitochondrial toxins such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [57-59]. Here, NGF is linked to Parkinson disease.